Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316362901> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4316362901 endingPage "74" @default.
- W4316362901 startingPage "70" @default.
- W4316362901 abstract "There is much evidence that the ABO blood group system may play a role in the pathogenesis of the disease. The relationship between ABO and Rhesus blood groups and cancer risk has been demonstrated in many research works. However, concerning gynaecological malignancies, these findings are inconsistent. This study aimed to evaluate the frequency of ABO and Rh-D blood groups in patients with carcinoma cervix. This cross-sectional study was conducted in the Department of Transfusion Medicine, Department of Gynaecological Oncology and Department of Pathology of Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka. A total of 110 clinically suspected cervical cancer patients were included in this study. Pap smear tests was done in all cases and the patients were divided into case (Pap test positive) and control group (Pap test negative). A total of 55 patients were included in each group. Blood groups (ABO & Rh-D) of all the patients were recorded. A higher number of the patients in the cervical cancer group were multiparous than in the control group. Almost in two-thirds of the population, the age of marriage was <18 years in the cervical cancer group compared to 34.5% in the control group. More than one-third population had “O” blood group in the case group, while it was 31% in the control group. The almost equal number had Rh D+ve in the case and control (92.7% vs. 94.5%). The differences between the blood group and Rh D were not statistically significant between the two groups. Nearly half (40.0%) of the participants had used a hormonal contraceptive in the case and 61.8% in control. The differences in hormonal contraceptives use were statistically significant within the two groups. The distribution of “O” blood group and Rh D +ve cases was found to be higher in patients with cervical cancer than in non-cancer patients although the difference was not statistically significant. BSMMU J 2022; 15(2): 70-74" @default.
- W4316362901 created "2023-01-16" @default.
- W4316362901 creator A5007903825 @default.
- W4316362901 creator A5035547834 @default.
- W4316362901 creator A5039307616 @default.
- W4316362901 creator A5044539756 @default.
- W4316362901 creator A5045472832 @default.
- W4316362901 creator A5061463505 @default.
- W4316362901 creator A5088382092 @default.
- W4316362901 date "2023-01-16" @default.
- W4316362901 modified "2023-09-30" @default.
- W4316362901 title "Frequency of ABO and Rh-D blood groups in cervical cancer" @default.
- W4316362901 doi "https://doi.org/10.3329/bsmmuj.v15i2.60857" @default.
- W4316362901 hasPublicationYear "2023" @default.
- W4316362901 type Work @default.
- W4316362901 citedByCount "0" @default.
- W4316362901 crossrefType "journal-article" @default.
- W4316362901 hasAuthorship W4316362901A5007903825 @default.
- W4316362901 hasAuthorship W4316362901A5035547834 @default.
- W4316362901 hasAuthorship W4316362901A5039307616 @default.
- W4316362901 hasAuthorship W4316362901A5044539756 @default.
- W4316362901 hasAuthorship W4316362901A5045472832 @default.
- W4316362901 hasAuthorship W4316362901A5061463505 @default.
- W4316362901 hasAuthorship W4316362901A5088382092 @default.
- W4316362901 hasBestOaLocation W43163629011 @default.
- W4316362901 hasConcept C121608353 @default.
- W4316362901 hasConcept C121857725 @default.
- W4316362901 hasConcept C126322002 @default.
- W4316362901 hasConcept C131872663 @default.
- W4316362901 hasConcept C159654299 @default.
- W4316362901 hasConcept C176080213 @default.
- W4316362901 hasConcept C203014093 @default.
- W4316362901 hasConcept C2777740455 @default.
- W4316362901 hasConcept C2778220009 @default.
- W4316362901 hasConcept C2779599708 @default.
- W4316362901 hasConcept C2780014101 @default.
- W4316362901 hasConcept C2908647359 @default.
- W4316362901 hasConcept C29456083 @default.
- W4316362901 hasConcept C71924100 @default.
- W4316362901 hasConcept C90924648 @default.
- W4316362901 hasConcept C99454951 @default.
- W4316362901 hasConceptScore W4316362901C121608353 @default.
- W4316362901 hasConceptScore W4316362901C121857725 @default.
- W4316362901 hasConceptScore W4316362901C126322002 @default.
- W4316362901 hasConceptScore W4316362901C131872663 @default.
- W4316362901 hasConceptScore W4316362901C159654299 @default.
- W4316362901 hasConceptScore W4316362901C176080213 @default.
- W4316362901 hasConceptScore W4316362901C203014093 @default.
- W4316362901 hasConceptScore W4316362901C2777740455 @default.
- W4316362901 hasConceptScore W4316362901C2778220009 @default.
- W4316362901 hasConceptScore W4316362901C2779599708 @default.
- W4316362901 hasConceptScore W4316362901C2780014101 @default.
- W4316362901 hasConceptScore W4316362901C2908647359 @default.
- W4316362901 hasConceptScore W4316362901C29456083 @default.
- W4316362901 hasConceptScore W4316362901C71924100 @default.
- W4316362901 hasConceptScore W4316362901C90924648 @default.
- W4316362901 hasConceptScore W4316362901C99454951 @default.
- W4316362901 hasIssue "2" @default.
- W4316362901 hasLocation W43163629011 @default.
- W4316362901 hasOpenAccess W4316362901 @default.
- W4316362901 hasPrimaryLocation W43163629011 @default.
- W4316362901 hasRelatedWork W2188609061 @default.
- W4316362901 hasRelatedWork W2288042885 @default.
- W4316362901 hasRelatedWork W2360979823 @default.
- W4316362901 hasRelatedWork W2364287543 @default.
- W4316362901 hasRelatedWork W2378592951 @default.
- W4316362901 hasRelatedWork W2418023340 @default.
- W4316362901 hasRelatedWork W2514884906 @default.
- W4316362901 hasRelatedWork W3024808116 @default.
- W4316362901 hasRelatedWork W4292949027 @default.
- W4316362901 hasRelatedWork W4382400723 @default.
- W4316362901 hasVolume "15" @default.
- W4316362901 isParatext "false" @default.
- W4316362901 isRetracted "false" @default.
- W4316362901 workType "article" @default.